-- UBS Group on Thursday downgraded in vitro diagnostic specialist DiaSorin (DIA.MI) to neutral from buy rating and reduced its price target to 66 euros from 84 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)